Cochrane Abstracts
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438204/all/PCSK9_monoclonal_antibodies_for_the_primary_and_secondary_prevention_of_cardiovascular_disease.
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/all/PCSK9_monoclonal_antibodies_for_the_primary_and_secondary_prevention_of_cardiovascular_disease. Accessed January 20, 2025.
PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/all/PCSK9_monoclonal_antibodies_for_the_primary_and_secondary_prevention_of_cardiovascular_disease
PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/all/PCSK9_monoclonal_antibodies_for_the_primary_and_secondary_prevention_of_cardiovascular_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease
ID - 438204
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438204/all/PCSK9_monoclonal_antibodies_for_the_primary_and_secondary_prevention_of_cardiovascular_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
